Progenis Pharmaceuticals

Recce Pharmaceuticals Ltd, located in Bentley, Western Australia, is at the forefront of developing innovative synthetic anti-infectives aimed at combating the global health crisis posed by antibiotic-resistant superbugs. Their proprietary products target both bacteria and viruses, featuring a universal mechanism of action that maintains potency even with repeated use, addressing significant medical needs in the field of infectious diseases. The company's pipeline includes multiple clinical candidates in Phase III trials, including a registrational trial in Indonesia, showcasing a commitment to providing therapeutic options for challenging bacterial infections and their mutated forms. Recce Pharmaceuticals is dedicated to enhancing its product offerings to effectively tackle difficult infections that are resistant to existing treatments. Generated from the website

Novacina Bridgewest Perth Pharma, located in Bentley, Western Australia, serves as a global Contract Development and Manufacturing Organization (CDMO) focused on accelerating the delivery of innovative therapies. With a commitment to quality and timely delivery, the company specializes in a wide range of services including process development, GMP manufacturing, and analytical development for microbial products, plasmid DNA, mRNA, and various drug formulations. Boasting state-of-the-art facilities in Perth and Adelaide, Novacina Bridgewest is dedicated to maintaining the highest standards of compliance and quality throughout the product lifecycle. Their experienced teams prioritize collaboration and client relationships, ensuring that every project is handled with the utmost care and expertise. Generated from the website